David S. Wilkes's most recent trade in Baxter International Inc. was a trade of 7,183 Common Stock, $1 par value done . Disclosure was reported to the exchange on May 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Baxter International | David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 7,183 | 23,906 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 5,952 | 16,274 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Syneos Health Inc - Ordina... | David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 4,863 | 9,836 (0%) | 0% | 0 | Class A Common Stock | |
| Baxter International | David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 4,573 | 10,034 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Syneos Health Inc - Ordina... | David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 2,839 | 4,973 (0%) | 0% | 0 | Class A Common Stock | |
| Baxter International | David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 5,339 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 2,230 | 2,597 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | David S. Wilkes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 366 | 366 (0%) | 0% | - | Common Stock, $1 par value |